Bright Minds Biosciences Investigation Continues: Investors May Contact Kirby McInerney LLP, a Securities Fraud Law Firm, If You Lost Money On Your DRUG Investments
New York, New York--(Newsfile Corp. - November 18, 2026) - The law firm of Kirby McInerney LLP continues its investigation on behalf of Bright Minds Biosciences ("Bright Minds" or the "Company") (NASDAQ: DRUG) investors concerning the Company's and/or members of its senior management's possible violation of the federal securities laws and other unlawful business practices. [CONTACT THE FIRM IF YOU SUFFERED A LOSS] What Happened?On November 2, 2026, Bright Minds announced that the FDA had...